Company news
RepliCel Life Sciences Inc. news in 2016
RepliCel Life Sciences Inc.'s news releases, calls and decks from 2016, newest first.
RepliCel Life Sciences Share Consolidation Approved
August 9, 2016
RepliCel Life Sciences Continues Restructuring With Share Structure Consolidation
July 22, 2016
RepliCel's Cell Therapy for Pattern Baldness Proceeds to Clinical Trial Launch in Japan
July 21, 2016
RepliCel Life Sciences Extends Warrant Expiry Dates and Amends Warrant Exercise Price
April 29, 2016
RepliCel Life Sciences Conducts Formal Consultation Review With Japan's PMDA and Receives Unprecedented Review Fee Reduction
April 25, 2016
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
April 20, 2016
RepliCel Life Sciences Applies to Amend Warrant Exercise Price and Extend Warrant Expiry Dates
April 8, 2016
RepliCel Life Sciences Announces Restructuring, Cost Reductions and Closing of Private Placement
April 6, 2016
RepliCel Life Sciences Inc. Announces Closing of Warrant Incentive Program
February 26, 2016
RepliCel Announces CEO Update
February 16, 2016
RepliCel Receives European Patent for its Innovative Dermal Injector Technology
January 11, 2016